PT  - JOURNAL ARTICLE
AU  - Martín, M Carmen
AU  - González, M Isabel
AU  - Holgado, Nuria
AU  - Jimenez, Ana I
AU  - Ortega, Nuria
AU  - Page, Isabel
AU  - Parrado, Alba
AU  - Pérez, María
AU  - Blanco-Peris, Lydia
TI  - Sustained SARS-CoV-2 seroprevalence and related hematological features in asymptomatic blood donors
AID  - 10.1101/2021.04.28.21256242
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.04.28.21256242
4099  - http://medrxiv.org/content/early/2021/06/04/2021.04.28.21256242.short
4100  - http://medrxiv.org/content/early/2021/06/04/2021.04.28.21256242.full
AB  - Background and objectives COVID-19 can either cause death or go unnoticed but antibodies will remain protecting us of SARS-CoV-2 reinfection for an uncertain time and to a uncertain extent. Knowledge of COVID-19 epidemiological and hematological features should help make a good forecast of resources for possible future outbreaks or vaccination strategies, and would facilitate decisions in the social sphere by a more reliable estimate of the percentage of immunized individuals. Our aim was to describe seroprevalence evolution from summer 2019 to autumn 2020 in Spain and to determine its relationship with age, blood group or haematological parameters.Materials and methods Sera and plasma from historical donation archives were randomized and a total of 12,718 samples tested by a Chemiluminiscent analysis for anti SARS-CoV-2 N protein total immunoglobulins. Blood donors were 60.9% males, average age 46+/-13. Sex, age, blood group, blood cell counts and percentages and immunoglobulin concentrations were extracted from electronic recordings.Results 6.7% donors were positive by the end of 1st wave. No differences by sex, age or blood group were found regarding antibodies. Leukocyte and neutrophil counts were lower (p<0.001) and haemoglobin was lower (p<0.001) in positive donations than in negative ones. Sex differences were found in neutrophils, leukocytes, haemoglobin and haematocrit as related to SARS-CoV-2 antibodies.Conclusions Seroprevalence due to asymptomatic cases would be slightly lower than the overall one due to age restrictions for blood donors. Sex and age would not affect COVID-19 susceptibility but its severity. Gender differences would be present in asymptomatic individuals. Further studies are needed to confirm these gender differences as they can help better understand the immune response to COVID-19, its pathogenesis and prognosis.Competing Interest StatementThis work has been carried out provided free equipment and test reagents from Roche Diagnostics International Ltd. M Carmen Martin spoke about this issue in a sponsored symposium of Roche Diagnostics International Ltd.Funding StatementThis work has been carried out provided free equipment and test reagents from Roche Diagnostics International Ltd.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was conducted according with national regulations, institutional policies and in the tenets of the Helsinki Declaration. This study was approved, with the Valladolid Health Area Drug Research Ethics Committee acting as the main committee, in a meeting held on June 11, 2020 with the reference number BIO-2020-93All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData collected for the study, including fully anonymized participant data, are available to others. Data available include fully anonymized participant data and data dictionary. Related documents are available from the date of publications henceforth: study protocol, statistical analysis, and approval of Ethical Board. These documents are available from the date of publications henceforth at email address cmartinalo@saludcastillayleon.es. Data would be shared after approval of proposals by the Valladolid Este Ethical Committee.(IgG)Immunoglobulin G(IgA)immunoglobulin A(IgM)immunoglobulin M(PCR)polymerase chain reaction(SD)standard deviation(IQR)interquartile range(WBC)White blood cells(Hb)haemoglobin(HCT)haematocrit(MCV)mean corpuscular volume